Kerala Ayurveda Limited (BOM:530163)
India · Delayed Price · Currency is INR 178.85
+0.85 (0.48%)
At close: Jun 16, 2026
Kerala Ayurveda Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,311 | 1,203 | 1,032 | 934.13 | 803.54 |
Other Revenue | - | - | - | 2.1 | 0.91 |
| 1,311 | 1,203 | 1,032 | 936.23 | 804.44 | |
Revenue Growth (YoY) | 8.98% | 16.66% | 10.18% | 16.38% | 29.59% |
Cost of Revenue | 275.85 | 238.62 | 231.23 | 212.77 | 179.42 |
Gross Profit | 1,036 | 964.71 | 800.28 | 723.47 | 625.03 |
Selling, General & Admin | 670.48 | 669.63 | 391.91 | 364.26 | 282.47 |
Other Operating Expenses | 542.62 | 344.99 | 323.05 | 299.68 | 232.44 |
Operating Expenses | 1,268 | 1,064 | 736.38 | 675.01 | 526.93 |
Operating Income | -232.36 | -99.66 | 63.9 | 48.46 | 98.1 |
Interest Expense | -73.4 | -26.44 | -46.35 | -48.22 | -65.2 |
Interest & Investment Income | - | 3.35 | 1.64 | 0.77 | 2.55 |
Currency Exchange Gain (Loss) | - | 18.59 | 1.44 | -34.94 | -15.38 |
Other Non Operating Income (Expenses) | 142.11 | -18.19 | -14.08 | - | - |
EBT Excluding Unusual Items | -163.64 | -122.36 | 6.56 | -33.94 | 20.07 |
Other Unusual Items | - | - | - | 28.35 | 7.97 |
Pretax Income | -163.64 | -122.36 | 6.56 | -5.59 | 28.04 |
Income Tax Expense | -0.4 | 17.23 | 12.16 | -1.31 | 4.11 |
Earnings From Continuing Operations | -163.25 | -139.59 | -5.6 | -4.28 | 23.93 |
Minority Interest in Earnings | -2.32 | - | - | -4.73 | -0.32 |
Net Income | -165.57 | -139.59 | -5.6 | -9.01 | 23.61 |
Net Income to Common | -165.57 | -139.59 | -5.6 | -9.01 | 23.61 |
Shares Outstanding (Basic) | 12 | 12 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 12 | 12 | 11 | 11 | 11 |
Shares Change (YoY) | 1.70% | 10.28% | 3.35% | - | -0.41% |
EPS (Basic) | -13.53 | -11.60 | -0.51 | -0.85 | 2.24 |
EPS (Diluted) | -13.53 | -11.60 | -0.51 | -0.85 | 2.24 |
Free Cash Flow | -297.5 | -84.95 | -20.54 | 36.75 | -33.51 |
Free Cash Flow Per Share | -24.31 | -7.06 | -1.88 | 3.48 | -3.17 |
Gross Margin | 78.97% | 80.17% | 77.58% | 77.27% | 77.70% |
Operating Margin | -17.72% | -8.28% | 6.19% | 5.18% | 12.19% |
Profit Margin | -12.63% | -11.60% | -0.54% | -0.96% | 2.94% |
Free Cash Flow Margin | -22.68% | -7.06% | -1.99% | 3.93% | -4.17% |
EBITDA | -177.5 | -78.6 | 81.04 | 59.53 | 110.11 |
EBITDA Margin | -13.53% | -6.53% | 7.86% | 6.36% | 13.69% |
D&A For EBITDA | 54.86 | 21.06 | 17.14 | 11.08 | 12.02 |
EBIT | -232.36 | -99.66 | 63.9 | 48.46 | 98.1 |
EBIT Margin | -17.72% | -8.28% | 6.19% | 5.18% | 12.19% |
Effective Tax Rate | - | - | 185.41% | - | 14.66% |
Revenue as Reported | 1,454 | 1,222 | 1,035 | 937 | 807 |
Advertising Expenses | - | 91.9 | 22.81 | 43.77 | 27.31 |